INFORMAL CARE COST IN NEUROLOGIC DISORDERS WITH THE CONTINGENT VALUATION METHOD

Author(s)

Dalaudiere J1, Rabier H2, Grguric G1, Hoarau D1, COLIN C1, Serrier H3, Fares A1
1HOSPICES CIVILS DE LYON, LYON, France, 2HESPER, Lyon, France, 3HOSPICES CIVILS DE LYON, 69424 Lyon cedex 03, 69, France

OBJECTIVES : To realize the first estimate of the cost of informal care associated with epilepsy, Parkinson disease (PD), and multiple sclerosis (MS) with the contingent valuation method (CVM).

METHODS : Individuals with MS (n=58), PD (n=96), or epilepsy (n=193) declaring informal caregivers in the French Health and disabilities households survey (Enquête Handicap-Santé) were classified in non-dependent, moderate and severe levels of dependency for the activities in daily living. The mean cost of informal care from the main caregiver per year was calculated with the Proxy Good (PGM), Opportunity Cost (OCM), and CVM methods.

RESULTS : The monthly mean (standard deviation, SD) number of informal care hours per care recipients was 142 (201) in PD, 138 (170) in MS, and 151 (180) in epilepsy. It increased with the level of dependency. The PGM and OCM produced similar costs (mean difference [SD] of €243 [440]). The CVM produced greater costs in severely dependent forms- (mean cost [SD] of €187,029 [328,058] versus €25,685 [22,520] for both OCM and PGM in MS; and €41,915 [38,157] with CVM versus €34,627 [25,263] with OCM, and €34,545 [25,308] with PGM in epilepsy).

CONCLUSIONS : By revealing the preferences of informal caregivers, the CVM could catch intangible effects of informal care related to severe MS and epilepsy, compared to PGM and OCM which consider only the effect on caregivers’ productivity in the labour market. However, numerous methodological questions remain about the calculation of the informal care cost and its implementation in economic evaluations.

Conference/Value in Health Info

2019-11, ISPOR Europe 2019, Copenhagen, Denmark

Code

PND57

Topic

Economic Evaluation

Topic Subcategory

Thresholds & Opportunity Cost, Trial-Based Economic Evaluation

Disease

Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×